Literature DB >> 27489118

Diagnostic accuracy of procalcitonin and presepsin for infectious disease in patients with acute kidney injury.

Gaku Takahashi1, Shigehiro Shibata2, Yasuo Fukui3, Yoshikazu Okamura4, Yoshihiro Inoue2.   

Abstract

Procalcitonin (PCT) and presepsin (PSEP) are sepsis markers, but their diagnostic accuracy may be compromised in acute kidney injury (AKI). We evaluated their diagnostic accuracy in patients with/without AKI. This retrospective study comprised 91 patients with at least one criterion of systematic inflammatory response syndrome. AKI markers plasma neutrophil gelatinase-associated lipocalin (NGAL), plasma cystatin C (CysC), and estimated glomerular filtration rate (eGFR) were measured upon hospital admission and on days 1, 3, 5, and 7. Patients were divided into non-AKI and AKI groups. APACHE II severity scores were determined. PCT and PSEP levels were increased significantly in non-AKI and AKI patients with infection. NGAL, CysC, and eGFR in patients with infection were associated with PCT, PSEP, and APACHE II score, and levels of PCT and PSEP were correlated significantly with disease severity. PCT and PSEP are useful markers of bacterial infections in AKI but different thresholds should be applied.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Biomarker; Diagnosis; Infection; Presepsin; Procalcitonin

Mesh:

Substances:

Year:  2016        PMID: 27489118     DOI: 10.1016/j.diagmicrobio.2016.07.015

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  10 in total

Review 1.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

2.  A Patient of Using Presepsin to Diagnose Streptococcal Toxic Shock Syndrome during Anticancer Drug Treatment.

Authors:  Gaku Takahashi
Journal:  Case Rep Crit Care       Date:  2019-04-16

3.  Presepsin and procalcitonin as predictors of sepsis based on the new Sepsis-3 definitions in obstructive acute pyelonephritis.

Authors:  Mitsuhiro Tambo; Satoru Taguchi; Yu Nakamura; Takatsugu Okegawa; Hiroshi Fukuhara
Journal:  BMC Urol       Date:  2020-03-11       Impact factor: 2.264

4.  Presepsin cut-off value for diagnosis of sepsis in patients with renal dysfunction.

Authors:  Kimika Arakawa; Ayako Saeki; Reo Ide; Yoshiteru Matsushita
Journal:  PLoS One       Date:  2022-09-14       Impact factor: 3.752

Review 5.  Biomarkers for the Prediction and Judgement of Sepsis and Sepsis Complications: A Step towards precision medicine?

Authors:  Thilo von Groote; Melanie Meersch-Dini
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964

6.  Presepsin and prognostic nutritional index are predictors of septic acute kidney injury, renal replacement therapy initiation in sepsis patients, and prognosis in septic acute kidney injury patients: a pilot study.

Authors:  Yuichiro Shimoyama; Osamu Umegaki; Noriko Kadono; Toshiaki Minami
Journal:  BMC Nephrol       Date:  2021-06-12       Impact factor: 2.388

7.  Presepsin in the Rapid Response System for Cancer Patients: A Retrospective Analysis.

Authors:  Min-Jung Lee; Won-Ho Han; June-Young Chun; Sun-Young Kim; Jee-Hee Kim
Journal:  J Clin Med       Date:  2021-05-16       Impact factor: 4.241

Review 8.  Predictive Ability of Procalcitonin for Acute Kidney Injury: A Narrative Review Focusing on the Interference of Infection.

Authors:  Wei-Chih Kan; Ya-Ting Huang; Vin-Cent Wu; Chih-Chung Shiao
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

9.  Prediction of Postoperative Sepsis Based on Changes in Presepsin Levels of Critically Ill Patients with Acute Kidney Injury after Abdominal Surgery.

Authors:  Chang Hwan Kim; Eun Young Kim
Journal:  Diagnostics (Basel)       Date:  2021-12-09

10.  Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients.

Authors:  Radim Dobiáš; Marcela Káňová; Naděžda Petejová; Štefan Kis Pisti; Robert Bocek; Eva Krejčí; Helena Stružková; Michaela Cachová; Hana Tomášková; Petr Hamal; Vladimír Havlíček; Milan Raška
Journal:  J Fungi (Basel)       Date:  2022-03-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.